Approach to Acute Pain Management
|
|
- Teresa Weaver
- 6 years ago
- Views:
Transcription
1 Approach to Acute Pain Management Jeanie Youngwerth, MD University of Colorado School of Medicine Associate Professor of Medicine, Hospitalist Director, Palliative Care Service Associate Director, Colorado Palliative Medicine Fellowship Program Medical Director, Halcyon Hospice and Palliative Care Pain: Objectives Discuss principles for opioid dosing and titration for acute pain Describe adjustments for opioids in the setting of renal or liver failure Apply equianalgesic opioid conversions in acute pain management Trivia Which technique has been associated with decreased acute pain levels? 1. Submerging the effected area in ice 2. Exposing the effected area to sun 3. Using profanity during the episode 4. Squeezing someone s hand during the episode Stephens: NeuroReport 2009; Stephens: Journal of Pain 2011.
2 Bonus Trivia: True / False? Habituation related to frequency of daily swearing can decrease the effectiveness of swearing as a short-term intervention to reduce pain. Pain Case Study 38 y/o M with pain from metastatic thymus cancer Diagnosed 6 years ago, persistent pain Recent scans show disease progression Admitted for acute pain crisis NKDA Cr 2.1 Pain Case Study Pain regimen: Morphine SR 90 mg po BID Oxycodone/APAP 5 mg po q4-6 hrs prn 12 tabs/day Seen in clinic 1 day ago, started on: Fentanyl 25 mcg/hr TD q3 days Dilaudid 4 mg po q6 hrs prn
3 Pain Case Study Pain regimen: Gabapentin 900 mg po TID Duloxetine 60 mg daily Dexamethasone 8 mg po daily RFA 1 month ago Pain Case Study What do you recommend? 1. Wean off of opioids as he is developing hyperalgesia 2. Switch to Hydromorphone as Morphine is no longer effective for him 3. Begin PCA for rapid control of pain 4. Increase Fentanyl TD which is more effective for patients with end-stage cancer Acute Pain Control PCAs Improved pain control Higher patient satisfaction Negative feedback system / safety measure Ballantyne: J Clin Anesth 1993; Sidebotham: J Pain Symptom Manage 1997; Hudcova: Cochrane Reviews 2006.
4 PCA Errors #1 PCA error is: 1. Improper dose/quantity 2. Wrong administration technique 3. Wrong patient US Pharmacopeia 2004; Hicks: Am J Health Syst Pharm * Pain Pearl * Avoid mixing opioids Avoid Mixing Opioids é risk for confusion and mistakes by patients and providers SIMPLIFY Morphine SR + Morphine IR prn
5 Oral Opioid Therapy Opioid breakthrough pain dosing (prn) Dose: 10-15% of 24 hour total opioid dose Interval: time to peak effect Opioid routine dosing (scheduled) Schedule IR every 4 hours IR (t½ = 2-4 hours) Consider SR (once pain stabilizes for ~48 hrs) Choice of Opioid What is considered the gold standard opioid? Grass: Anesth Analg * Pain Pearl * Avoid Morphine in renal failure
6 Renal Failure (RF) Majority of opioids renally cleared Recommendations based on presence of active metabolites Limited studies; no RCTs No consensus on GFR to define RF dose reductions Dean: J Pain Symptom Manage 2004; King: Palliat Med Renal Failure Morphine, Codeine Potent, active metabolites cleared renally Increased risk for neurotoxicity Avoid in RF Hydromorphone, Oxycodone, Tramadol Poorly studied Cautious dosing Fentanyl Limited studies No known active renal metabolites No dose adjustment short term in RF consider decreasing dose long term Dean: J Pain Symptom Manage 2004; King: Palliat Med Liver Failure Impaired oxidation and glucuronidation Limited studies- most extrapolated from RF High prevalence & risk of RF in cirrhosis Avoid Morphine, Codeine, Tramadol Transdermal preparations Davis: Clin Pharmacokinet 2007; Rhee: J Palliat Med 2007; Chandok: Mayo Clin Proc 2010.
7 Renal and Liver Failure Summary Avoid Morphine Fentanyl safer choice Oxycodone and Hydromorphone cautious dosing Consider IR preparations Consider longer dosing intervals Pain Case Study Opioid switch from Morphine PCA IV Hydromorphone Pain Case Study Pain regimen: Morphine SR 90 mg po BID = 180 mg po Oxycodone 5 mg/apap 12 tabs/day= 60 mg Seen in clinic 1 day ago, started on: Fentanyl 25 mcg/hr TD q3 days Dilaudid 4 mg po q6 hrs prn
8 Opioid Conversions Equianalgesic Dosing 1. Calculate total 24 hour total opioid dose 2. Convert to 24 hour new opioid equivalent 3. Adjust by 50-75% for incomplete cross tolerance 4. Triple check calculations 5. Constipation prophylaxis! EPEC Module ; v1.0; NCCN: Adult Cancer Pain v Incomplete Cross Tolerance When switching from one opioid to another Tolerance developed to one opioid may not completely transfer to the new opioid Start the new opioid at 50-75% of the equianalgesic dose 60% good generalization Pasternak: Trends in Pharm Sciences 2001; Ballantyne: NEJM 2003; Mehta: Anaesth 2006; ; v1.0; NCCN: Adult Cancer Pain v
9 Opioid Conversions Equianalgesic Dosing Current Opioid Total 24 hour Current Opioid = New Opioid Total 24 hour New Opioid (X) Pain Case Study 1. Calculate total 24 hour total opioid dose Current Opioid New Opioid = Total 24 hour Current Total 24 hour New Oxycodone 20 mg po Morphine 30 mg po = Oxycodone 60 mg/day po Morphine X X = Morphine 90 mg po/day Pain Case Study Morphine SR 180 mg/d po + Oxycodone Morphine 90 mg/d po TDD = Morphine 270 mg po/d
10 Pain Case Study 2. Convert to 24 hour new opioid equivalent Current Opioid New Opioid = Total 24 hour Current Total 24 hour New Morphine 30 mg po Hydromorphone 1.5 mg IV = Morphine 270 mg po/d Hydromorphone X X = Hydromorphone 13.5 mg IV/day Pain Case Study 3. Adjust by 60% for incomplete x- tolerance Hydromorphone 13.5 mg IV/day X 0.6 = Hydromorphone 8.1 mg IV/day * Pain Pearl * Adjust for incomplete cross tolerance with equianalgesic dose conversions
11 Pain Case Study 4. Triple check calculations 5. Constipation prophylaxis! -Senna 2 tabs po BID Hawley: JPSM 2008; Librach: JPSM 2010; Tarumi: JPSM Pain Case Study Hydromorphone 8.1 mg IV/day 24 hrs = 0.3 mg/hr PCA settings? PCA Management FIRST ask yourself Opioid naïve or not??? PCA Parameters Basal Demand Lockout
12 PCA Basal Rate- Opioid Tolerant Opioid tolerant Convert 24 hour total opioid requirement to hourly rate (by equianalgesic dosing) Macintrye: Br J Anaesth 2001; Lehmann: J Pain Symptom Manage 2005; Grass: Anesth Analg PCA Basal Rate- Opioid Naïve Opioid naïve No basal rate Increased rates of respiratory depression No improvement in pain scores Sidebotham: JPSMx 1997; Macintrye: Br J Anaesth 2001; Krenn: Euro J Pain 2001; Didem: Can J Anesth 2003; Grass: Anesth Analg 2005; Herr: Iowa City Guideline Summary NGC
13 PCA Demand Dose- Opioid Tolerant Demand dose 50% of the basal rate (50-100%) Grass: Anesth Analg PCA Demand Dose- Opioid Naive Morphine 0.5, 1, 2mg 0.5 mg unable to achieve adequate analgesia 2 mg higher rates of respiratory depression 1 mg optimum starting dose Owen: Anaesth 1989; Sidebotham: J Pain Symptom Manage PCA Lockout Time Based on time to peak effect
14 Time to Peak Opioid Effect 10 min Opioid Time to Peak Effect Route of Administration Oral Time to Peak Effect 60 minutes Subcutaneous 30 minutes IV 10 minutes EPEC Module ; APS 2003; APS 2006; NCCN: Adult Cancer Pain v PCA Lockout Time Morphine 7 vs 11 minutes Fentanyl 5 vs 8 minutes No difference in pain relief, anxiety or side effects Ginsberg: Pain 1995.
15 PCA Lockout Time 10 minutes is a standard interval Ginsberg: Pain 1995; Macintrye: Br J Anaesth 2001; Walder: Acta Anaesthesiol Scand 2001; Grass: Anesth Analg PCA Nurse Initiated Bolus Not studied; Variable Twice the demand dose Grass: Anesth Analg PCA Dosing Summary Basal Rate Opioid naïve: none Opioid tolerant: Convert 24 hour total opioid requirement to hourly rate (by equianalgesic dosing) Demand Dose Opioid naïve: 1 mg IV Morphine equivalent Opioid tolerant: 50% (100%) of the basal rate Lockout Time 10 minutes Nurse Initiated Bolus 2x the demand dose
16 Pain Case Study Hydromorphone 0.3 mg/hour Basal 0.3 mg/hr Demand dose 0.2 mg Lockout time 10 min Nurse-bolus 0.4 mg Nurse calls for patient with severe pain. What is the best next step when titrating the PCA for acute pain control? 1. Increase basal rate to 0.5 mg/hr 2. Increase demand dose to 0.4 mg 3. Decrease lockout time to 6 minutes 4. Change PCA opioid to Fentanyl 5. Add Oxycodone SR 10 mg PO BID Opioid Titration Acute control: immediate release/prn Demand dose Chronic control: sustained release/scheduled Basal rate Hanks: British J Cancer 2001; Grass: Anesth Analg 2005.
17 Opioid Titration Pain Severity Increase Dose Up To Mild 25% Moderate 50% Severe 100% EPEC Module ; NCCN: Adult Cancer Pain v * Pain Pearl * Avoid increasing the dose of opioid by more than 100% at any one time! PCA Demand Dose Titration Demand dose Can change every minutes if needed Practically every 60 minutes and reevaluate
18 PCA Basal Rate Titration Basal rate 8-24 hours to achieve steady state Avoid changing more frequently than q 8 hrs Every 24 hours reasonable EPEC Module ; APS PCA Basal Rate Titration Dose based on 24 hour total opioid usage Patient pain rating Your assessment Daily trend of 24 hr requirements Opioid Titration Summary Basal rate Consider change ~ daily based on 24 hour opioid usage in opioid-tolerant Demand dose Titrate for acute pain control é 25% mild pain é 50% moderate pain é 100% severe pain Lockout time Keep at 10 min
19 PCA to Oral Opioids Once stable opioid requirements for ~2 days Use TDD from PCA to calculate equianalgesic oral dose of new opioid Remember incomplete x-tolerance Pain Case Study PCA to Oral Opioid Current Opioid Total 24 hour Current New Opioid Total 24 hour New = Hydrom 1.5 mg IV = Hydrom 10mg/day IV Oxycodone 20 mg po Oxycodone X X = Oxycodone 133 mg po/day x 0.6 = 80 mg po/day = Oxycodone SR 40 mg po BID Oxycodone IR 10 mg po q1 hr prn pain Senna 2 tab po BID Creative QI Projects PCA Safety Checklist Safe, effective, rapid pain control with a standardized, transparent approach
20 Pa$ent has confirmed PCA Safety Checklist FOR ALL STEPS: Document excep6ons to any step of the safety checklist. Address psycho- social- spiritual pain. DECISION TO START PCA PCA INITIATION PCA TITRATION cogni$ve func$on physical capability Pa$ent and family educated Document PCA indica$on Discon$nue all other opioids CALCULATIONS GUIDELINES 40% reduc$on for cross tolerance when conver$ng to another opioid For basal and demand: Is demand % of basal rate? Is RN bolus % of demand? Is demand lockout 10 minutes? Double check calcula$ons with a pallia$ve care team member PCA conversion verbally communicated to primary team and nurse Is pa$ent IPC bed status? Document conversion calcula$ons (.pccalc and.pcpca) CALCULATIONS GUIDELINES Incremental 24 hour basal rate increase not to exceed 100% of previous basal rate For basal and demand: Is demand % of basal rate? Is RN bolus % of demand? Is demand lockout 10 minutes? Double check previous 24 hour use with a pallia$ve care team member Double check $tra$on calcula$ons with a pallia$ve care team member PCA $tra$on verbally communicated to primary team and nurse Document $tra$on calcula$ons (.pcpca) PCA Safety Checklist FOR ALL STEPS: Document excep6ons to any step of the safety checklist. Address psycho- social- spiritual pain. TRANSITIONING PCA TO PO Pa$ent has confirmed GI absorp$on renal func$on appropriate for medica$on CALCULATIONS GUIDELINES Stable PCA use x 48 hours 40% reduc$on for cross tolerance when conver$ng to another opioid Is oral PRN dose 10-15% of total daily dose? Double check calcula$ons with a pallia$ve care team member Pa$ent has confirmed outpa$ent insurance coverage outpa$ent provider follow up PO conversion verbally communicated to primary team and nurse Document conversion calcula$ons (.pccalc) PCA DISCONTINUATION Discon$nue basal within 4 hours of star$ng long ac$ng po Con$nue demand as PRN for hours ayer star$ng long ac$ng po for high dose conversions WHEN TRANSITIONING TO FENTANYL PATCH Discon$nue basal 6 hours ayer patch ini$a$on UPON DISCHARGE Pain medica$on regimen on discharge communicated in wri$ng to outpa$ent provider / community pallia$ve care agency WHEN DISCHARGING WITH PCA Pa$ent has confirmed infusion company home health outpa$ent pallia$ve care outpa$ent provider to write PCA orders OR inpa$ent or home hospice agency Methadone Elderly Fentanyl TD Caveats
21 Methadone Does not follow regular opioid principles! Recommend consulting Palliative Care or Pain Service for patients in acute pain crisis who are on Methadone Bruera: JPM Methadone Does not follow regular opioid principles! Recommend consulting Palliative Care or Pain Service for patients in acute pain crisis who are on Methadone Bruera: JPM Elderly- Opioid Reduction Require less opioid than younger patients to achieve same relief Opioid sensitivity é by 50% Pain intensity ê by 10-20% each decade after age 60 Herr: Iowa City Guideline Summary NGC
22 Elderly- Opioid Reduction Initiate opioids at 25-50% lower dose than recommended for younger adults Herr: Iowa City Guideline Summary NGC Evidence Grade = B; v1.0. Fentanyl TD Lipophilic Decreased absorption in cachectic Increased absorption with heat (fevers) Chronic, stable pain in opioid-tolerant Fentanyl TD 2x po Morphine 75 mcg/hr q3days 150 mg po daily NCCN: Adult Cancer Pain v Resources REMS GuestPageExternal.aspx NCCN Adult Cancer Pain Guidelines physician_gls/f_guidelines.asp
23 * Pain Pearls * Avoid mixing opioids Avoid Morphine with renal failure Adjust for incomplete cross tolerance (60%) Avoid increasing opioid dose by >100%
Opioid Use in Serious Illness
Opioid Use in Serious Illness Jeanie Youngwerth, MD University of Colorado School of Medicine Associate Professor of Medicine, Hospitalist Director, Palliative Care Service Associate Director, Colorado
More informationObjectives. Patient Controlled Analgesia (PCA) Management in the Seriously Ill. Discuss principles for opioid dosing and titration for acute pain
Patient Controlled Analgesia (PCA) Management in the Seriously Ill Jeanie Youngwerth, MD University of Colorado School of Medicine Associate Professor of Medicine, Hospitalist Associate Director, Colorado
More informationOpioid Pearls and Acute Pain Management
Opioid Pearls and Acute Pain Management Jeanie Youngwerth, MD University of Colorado Denver Assistant Professor of Medicine, Hospitalist Associate Director, Colorado Palliative Medicine Fellowship Program
More informationEquianalgesic Dosing: Making Opioid Interchange Easier. Joseph Bubalo PharmD, BCPS, BCOP Oncology Clinical Pharmacist Assistant Professor Of Medicine
Equianalgesic Dosing: Making Opioid Interchange Easier Joseph Bubalo PharmD, BCPS, BCOP Oncology Clinical Pharmacist Assistant Professor Of Medicine 1 Why Change Opioids? Side Effects Insufficient Pain
More informationOpioid Case Studies. Thomas P. Pittelkow, D.O., M.P.H. Mayo Clinic College of Medicine Rochester, MN. September 29, MFMER slide-1
Opioid Case Studies Thomas P. Pittelkow, D.O., M.P.H. Mayo Clinic College of Medicine Rochester, MN September 29, 2016 2015 MFMER slide-1 Disclosures Relevant Financial Relationship(s) None Off Label and/or
More informationGUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS
GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS Bristol Palliative Care Collaborative Contact Numbers: Hospital Specialist Palliative Care Teams: North Bristol 0117 4146392 UH Bristol 0117
More information4/3/2018. Management of Acute Pain Crises. Five Mistakes I ve made and why you shouldn t
Management of Acute Pain Crises Maggie O Connor, M.D. Retired Palliative Care Physician Hope is not the conviction that something will turn out well, but the certainty that something makes sense, regardless
More informationPAIN MANAGEMENT PGY-1. Aaron D. Storms, MD Carin van Zyl, MD Adult and Pediatric Palliative Care, LAC+USC Keck School of Medicine of USC
PAIN MANAGEMENT PGY-1 Aaron D. Storms, MD Carin van Zyl, MD Adult and Pediatric Palliative Care, LAC+USC Keck School of Medicine of USC Perception Matters A builder aged 29 came to the accident and emergency
More informationPain management. Coleman Palliative Care Conference: February 2016 Josh Baru MD Stacie Levine MD
Pain management Coleman Palliative Care Conference: February 2016 Josh Baru MD Stacie Levine MD Case #1 61 yo man with history of Stage 3 colon cancer, s/p resection and adjuvant chemotherapy with FOLFOX
More informationOverview of Essentials of Pain Management. Updated 11/2016
0 Overview of Essentials of Pain Management Updated 11/2016 1 Overview of Essentials of Pain Management 1. Assess pain intensity on a 0 10 scale in which 0 = no pain at all and 10 = the worst pain imaginable.
More informationB. Long-acting/Extended-release Opioids
4 Opioid tolerance is assumed in patients already taking fentanyl 25 mcg/hr OR daily doses of the following oral agents for 1 week: 60 mg oral morphine, 30 mg oxycodone, 8 mg hydromorphone, 25 mg of oxymorphone
More informationLong Term Care Formulary HCD - 08
1 of 5 PREAMBLE Opioids are an important component of the pharmaceutical armamentarium for management of chronic pain. The superiority of analgesic effect of one narcotic over another is not generally
More informationOpioid Conversions Mixture of Science and Art
Opioid Conversions Mixture of Science and Art Matthew J. Pingree, MD Assistant Professor Division of Pain Medicine Physical Medicine and Rehabilitation and Anesthesiology Mayo Clinic, Rochester Pingree.Matthew@Mayo.edu
More informationPain Management in Hospice and Palliative Care
Pain Management in Hospice and Palliative Care A Case-based Approach JoAnne Nowak, M.D. Merrimack Valley Hospice Revised November 2011 Objectives Use a case study approach to stimulate discussion and illustrate
More informationPharmacologic Considerations for Managing Sickle Cell Pain Claire Saadeh, PharmD, BCOP May 5, 2015
Pharmacologic Considerations for Managing Sickle Cell Pain Claire Saadeh, PharmD, BCOP May 5, 2015 Table 1: Physiologic changes that occur during sickle cell pain crisis 1-3 Phase Description / Complications
More informationFighting the Good Fight: How to Convert Opioids Just Right!
Fighting the Good Fight: How to Convert Opioids Just Right! Tanya J. Uritsky, PharmD, BCPS, CPE Clinical Pharmacy Specialist - Pain Medication Stewardship Hospital of the University of Pennsylvania - Philadelphia,
More informationPAIN. TREATMENT TABLES Analgesics. NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose
NON-OPIOID SHORT-ACTING LONG-ACTING **** O PAIN TREATMENT TABLES Analgesics NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose Tramadol 50 mg Ultram Every 4 hours 1-2 tabs,
More informationANSWER # 1 PHARMACOLOGY. Methadone answers Stoltzfus 4/5/2012 METHADONE: WHY GRANDMA S TAKING A DIPHENYLHEPTANE (ANSWERS) JANUARY 26, 2017
METHADONE: WHY GRANDMA S TAKING A DIPHENYLHEPTANE (ANSWERS) JANUARY 26, 2017 Ky Stoltzfus, MD Assistant Professor, Internal Medicine University of Kansas Medical Center ANSWER # 1 Your response might be
More information2017 Opioid Prescribing Module 401 N. Ewing St. Lancaster, Ohio (740) ~
2017 Opioid Prescribing Module 401 N. Ewing St. Lancaster, Ohio 43130 (740) 687-8000 ~ www.fmchealth.org Introduction The purpose of this module is to reduce the risk of adverse outcomes for adult patients
More informationPain Management Dilemmas. Five Pain Dilemmas. Barriers: Meet Loretta. Daniel Johnson, MD, FAAHPM
Pain Management Dilemmas Daniel Johnson, MD, FAAHPM Kaiser Permanente University of Colorado Five Pain Dilemmas 1. Barriers to Pain Management 2. Selecting and Titrating Opioids 3. Managing PCAs 4. Using
More informationOpioid Rotation. Dr Bruno Gagnon, M.D., M.Sc.
Opioid Rotation Dr Bruno Gagnon, M.D., M.Sc. Associate Professor Department of Family Medicine and Emergency Medicine, Faculty of Medicine, Université Laval Consultant in Palliative Medicine CHU de Québec-Université
More informationTips for Managing Acute Pain
Tips for Managing Acute Pain Daniel Johnson, MD, FAAHPM Kaiser Permanente University of Colorado Session Outline 1. Pseudoaddiction 2. Opioid Selection 3. PCA Titration 4. Co-Analgesics 5. Breakthrough
More informationOpioid Conversion Guidelines
Opioid Conversion Guidelines March 2015 Gippsland Region Palliative Care Consortium Clinical Practice Group Title Keywords Ratified Opioid, Conversion, Drug, Therapy, Palliative, Guideline, Palliative,
More information1/21/14. Cancer Related Pain: Case-Based Pharmacology. Conflicts of Interest. Learning Objective
Cancer Related Pain: Case-Based Pharmacology Jeannine M. Brant, PhD, APRN, AOCN Oncology Clinical Nurse Specialist Nurse Scientist Billings Clinic Conflicts of Interest Jeannine Brant has served on the
More informationBASICS OF OPIOID PRESCRIBING 10:30-11:45AM
PROVIDING QUALITY CARE TO PAIN PATIENTS IN IOWA BASICS OF OPIOID PRESCRIBING 10:30-11:45AM ACPE UAN: 107-000-14-013-L01-P Activity Type: Application-Based 0.125 CEU/1.25hr Learning Objectives for Pharmacists:
More informationArresting Pain without Getting Arrested
G. Jay Westbrook, M.S., R.N., CHPN - Clinical Director Compassionate Journey: An End-of-Life Clinical & Education Service CompassionateJourney@hotmail.com 818/773-3700 Arresting Pain without Getting Arrested
More informationBJF Acute Pain Team Formulary Group
Title Analgesia Guidelines for Acute Pain Management (Adults) in BGH Document Type Issue no Clinical guideline Clinical Governance Support Team Use Issue date April 2013 Review date April 2015 Distribution
More informationPALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST
PALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST TREATMENT IN ONCOLOGY Main treatment : surgery Neoadjuvant treatment : RT, CMT Adjuvant treatment : Tx micrometastatic disease -CMT,Targeted
More informationOpioids in Serious Medical Illness
Opioids in Serious Medical Illness Jacob J. Strand, M.D. Assistant Professor of Medicine Medical Director, Palliative Care Clinical Services Mayo Clinic Mayo Clinic Opioid Conference 2013 MFMER slide-1
More informationPalliative Prescribing - Pain
Palliative Prescribing - Pain LAURA BARNFIELD 21/2/17 Aims To understand the classes of painkillers available in palliative care To gain confidence in counselling regarding opiates To gain confidence prescribing
More informationRELIEVING VIRGINIA S PAIN AND SUFFERING 3:45-4:45PM
PROVIDING QUALITY CARE TO PAIN PATIENTS IN IOWA RELIEVING VIRGINIA S PAIN AND SUFFERING 3:45-4:45PM ACPE UAN: 107-000-14-016-L05-P Activity Type: Application-Based 0.1 CEU/1.0 hr Learning Objectives for
More informationWhat to do when you are called to see a patient with... PAIN. Susan Merel, MD Division of General Internal Medicine July 2018
What to do when you are called to see a patient with... PAIN Susan Merel, MD Division of General Internal Medicine July 2018 Disclosures Susan Merel has no relationships with any entity producing, marketing,
More informationTHE EAPC OPIOID GUIDELINES: PROCESS, RESULTS AND FUTURE DEVELOPMENT
1 THE EAPC OPIOID GUIDELINES: PROCESS, RESULTS AND FUTURE DEVELOPMENT Jaegtvolden 4-5 June 2012 14. 12. 2012 2 1 3 WHO ANALGESIC LADDER (1996) NSAID +/- Adjuvant STEP II OPIODS Opids for mild to moderate
More informationAmber D. Hartman, PharmD Specialty Practice Pharmacist James Cancer Center & Solove Research Institute Ohio State University Medical Center
Pharmacologic Management of Pain Amber D. Hartman, PharmD Specialty Practice Pharmacist James Cancer Center & Solove Research Institute Ohio State University Medical Center Objectives Identify types of
More informationLumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes.
Reference Guide for PACU Lumbar Fusion CLINICAL PATHWAY All patient variances to the pathway are to be circled and addressed in the progress notes. This Clinical Pathway is intended to assist in clinical
More informationAcute pain management in opioid tolerant patients. Muhammad Laklouk
Acute pain management in opioid tolerant patients Muhammad Laklouk General principles An adequate review and assessment Provision of effective analgesia (including attenuation of tolerance and hyperalgesia)
More information10 mg hydrocodone equals how much oxycodone
Cari untuk: Cari Cari 10 mg hydrocodone equals how much oxycodone Posts about dilaudid 8 vs oxycodone 30 written by buyprescriptionmedication. Can you help me with the conversion of Oxycodone IR (5mg tab)
More informationWhat to do when you are called to see a pa2ent with... PAIN. Susan Merel, MD Division of General Internal Medicine July 2017
What to do when you are called to see a pa2ent with... PAIN Susan Merel, MD Division of General Internal Medicine July 2017 Disclosures Susan Merel has no rela2onships with any en2ty producing, marke2ng,
More informationSupportive Care. End of Life Phase
Supportive Care End of Life Phase Guidelines for Health Care Professionals In the care of patients with established renal failure who are in the last days of life References: Chambers E J (2004) End of
More informationSupporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety
Agitation & Anxiety (Exclude or treat REVERSIBLE causes*) Patient is anxious / frightened, but lucid Patient is confused, agitated and / or hallucinating MIDAZOLAM 2.5-5mg s/c (Max total 24 hour dose of
More informationE-Learning Module N: Pharmacological Review
E-Learning Module N: Pharmacological Review This Module requires the learner to have read Chapter 13 of the Fundamentals Program Guide and the other required readings associated with the topic. Revised:
More informationPitfalls in Pain Management: Practical Solutions for Hospitalists
Pitfalls in Pain Management: Practical Solutions for Hospitalists Liz Merkle Hankollari, M.D. Assistant Professor Hospital Medicine/General Internal Medicine Duke University Hospital Topics for Discussion
More information(30689) PROT Pain PCA Adult Patient Controlled Analgesia
Diagnosis Allergies Nursing Assess and Document PCA: 1. Assess and document pain rating, sedation level and respiratory rate every 2 hours; assess and document pain rating, sedation level and respiratory
More informationPRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT
PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT A collaboration between: St. Rocco s Hospice, Bridgewater Community Healthcare NHS Trust, NHS Warrington Clinical Commissioning Group,
More informationOPIOID- INDUCED NEUROTOXICITY*
OPIOID- INDUCED NEUROTOXICITY* Sriram Yennu MD, MS, FAAHPM Palliative Care, Rehabilitation and Integrative Medicine U.T. M.D. Anderson Cancer Center *Slide Deck courtesy Dept PRIM MDACC PATIENT #1: MRS
More informationInterprofessional Webinar Series
Interprofessional Webinar Series Opioids in the Medically Ill: Principles of Administration Russell K. Portenoy, MD Chief Medical Officer MJHS Hospice and Palliative Care Director MJHS Institute for Innovation
More informationBeyond The Lockout Time. Kelcy Freeman, PharmD, BCPS April 20, 2017 REMEDI Pump Collaborative Spring Conference Chicago, IL
Beyond The Lockout Time Kelcy Freeman, PharmD, BCPS April 20, 2017 REMEDI Pump Collaborative Spring Conference Chicago, IL Disclosure I am a full-time employee of Smiths Medical, global provider of medical
More informationJuly We hope that our tool will be a useful aid in your efforts to improve pain management in your setting. Sincerely, 7/14
July 2014 he Knowledge and Attitudes Survey Regarding Pain tool can be used to assess nurses and other professionals in your setting and as a pre and post test evaluation measure for educational programs.
More informationDose equivalent of fentanyl patch to oxycontin
Dose equivalent of fentanyl patch to oxycontin 10-3-2018 Detailed dosage guidelines and administration information for OxyContin (oxycodone hydrochloride). Includes dose adjustments, warnings and precautions.
More informationNarcotic Equivalence Converter Narcotic Route Dose Duration; Select a drug: mg Convert to: mg Adapted from Tarascon Pocket Pharmacopoeia.
Narcotic Equivalence Converter Narcotic Route Dose Duration; Select a drug: mg Convert to: mg Adapted from Tarascon Pocket Pharmacopoeia. Created: Monday, March 12. Online calculator to convert equianalgesic
More informationAttach patient label here. Physician Orders ADULT: Palliative Care Plan
Initiate Orders Phase Care Sets/Protocols/PowerPlans Initiate Powerplan Phase T;N, Phase: Palliative Care Phase, When to Initiate: Palliative Care Phase Admission/Transfer/Discharge Patient Status Initial
More informationPeri operative pain control. Disclosure. Objectives 9/1/2011. No current conflicts of interest
Peri operative pain control Chris Herndon, PharmD, FASHP Southern Illinois University Edwardsville Disclosure No current conflicts of interest Objectives Discuss studies evaluating the transformation of
More informationManaging Your Pa,ent s Complex Cancer Pain. Dr Eoin Tiernan Consultant in Pallia,ve Medicine UCD Associate Clinical Professor 30 th March 2019.
Managing Your Pa,ent s Complex Cancer Pain Dr Eoin Tiernan Consultant in Pallia,ve Medicine UCD Associate Clinical Professor 30 th March 2019. Terminology Background pain: Present for >12 hours a day during
More informationDemystifying Opioid Conversion Calculations
Demystifying Opioid Conversion Calculations Stephanie Cheng, PharmD, MPH, BCGP Clinical Pharmacist Hospice Pharmacy Solutions November 28, 2018 Learning Objectives After this presentation, you should be
More informationPalliative and Hospice Care of the Terminally Ill Introduction
Palliative and Hospice Care of the Terminally Ill Introduction There has been an increase in life expectancy for men and women of all races to 77.6 years Leading causes of death in older patients are chronic
More informationUse of PCA devices in Difficult Populations
Use of PCA devices in Difficult Populations Diane M. Santangelo MS RN ANP-C Stony Brook University Medical Center Acute Pain Service September 10, 2011 1 PCA technology? Why Bother? Costly Nurses complain:
More informationCare of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure.
Care of the Dying Early diagnosis of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance covers the prescribing and management of patients
More informationTo Infinity and Beyond! Safe and Effective Opioid Titration Strategies
To Infinity and Beyond! Safe and Effective Opioid Titration Strategies Alexandra L. McPherson, PharmD, MPH Slide development Mary Lynn McPherson, PharmD, MA, BCPS, CPE Professor and Executive Director,
More informationReview of Pain Management with Clinical and Regulatory Updates
Review of Pain Management with Clinical and Regulatory Updates Palliative Care Collaborative: 8 th Annual Regional Conference October 10, 2014 Michael Stellini, M.D.,M.S. Medical Director, Hospice and
More informationOvercoming Opioid-Induced Oversedation: More Than Meets the Eye
Overcoming Opioid-Induced Oversedation: More Than Meets the Eye ANCC National Magnet Conference 2013 Jeannine M. Brant, PhD, APRN, AOCN Lisa Peterson, RN-BC, BSN Health Care, Education and Research www.billingsclinic.com
More informationAnalgesics: Management of Pain In the Elderly Handout Package
Analgesics: Management of Pain In the Elderly Handout Package Analgesics: Management of Pain in the Elderly Each patient or resident and their pain problem is unique. A complete assessment should be performed
More informationPain Management in the
Pain Management in the Elderly Meri Hix, PharmD, CGP, BCPS Associate Professor of Pharmacy Practice Midwestern University Chicago College of Pharmacy No conflicts of interest to declare Objectives Discuss
More informationPalliative Care for Primary Care Providers QUYNH BUI, MD MPH DECEMBER 2015
Palliative Care for Primary Care Providers QUYNH BUI, MD MPH DECEMBER 2015 Objectives Define palliative care and primary palliative care Describe the rationale for providing primary palliative care in
More informationOpioid Pain Management. John Manfredonia, DO. Disclosures. Dr. Manfredonia discloses his employment as Regional Medical Director for VistaCare
Opioid Pain Management John Manfredonia, DO Disclosures Dr. Manfredonia discloses his employment as Regional Medical Director for VistaCare VistaCare has provided commercial support for this activity Palliative
More information15mg oxycodone is equivalent to how much morphine
15mg oxycodone is equivalent to how much morphine The Borg System is 100 % 15mg oxycodone is equivalent to how much morphine nursing home activity director cover letter 15 mg oxycodone equal to how much
More informationManagement of Cancer Pain
Management of Cancer Pain Mihir M. Kamdar, MD Associate Director, Palliative Care Director, MGH Cancer Pain Clinic Depts of Anesthesia Pain/Palliative Care Massachusetts General Hospital None Disclosures
More informationNATL. II. Health Net Approved Indications and Usage Guidelines: Diagnosis of cancer AND. Member is on fentanyl transdermal patches AND
Coverage of drugs is first determined by the member s pharmacy or medical benefit. Please consult with or refer to the Evidence of Coverage document I. FDA Approved Indications: The management of breakthrough
More informationObjectives. What is pain? 9/27/2017. Pain: Does this Hurt? Fall 2017 Dean Fox, MD, FACP
Pain: Does this Hurt? Fall 2017 Dean Fox, MD, FACP Photo credit: http://multiple-sclerosis-research.blogspot.com/2013/10/pain-and-unemployment.html Objectives Consider personal goal of pain management
More informationObjectives: What is your Definition of Pain? 8/16/2017
Safe Opioid Management for the Seriously Ill Patient Sam Perna, D.O. Objectives: MDB1 1) Participants will understand the way the body s pain system works. 2) Participants will identify the elements of
More informationPalliative Care Pearls: What Works, What Doesn t
: Steven Pantilat, MD Kates-Burnard and Hellman Distinguished Professor of Palliative Care Director, Palliative Care Program and Palliative Care Quality Network Department of Medicine University of California,
More informationReducing the risk of patient harm: A focus on opioids
Reducing the risk of patient harm: A focus on opioids New York State Partnership for Patients (NYSPFP) Initiative Regional Educational Session November 2013 1 Disclosure Matthew Fricker, Matthew Grissinger,
More informationAcute Pain Management in the Hospital Setting. Alexandra Phan, PharmD PGY-1 Pharmacy Practice Resident Medical Center Hospital Odessa, TX
Acute Pain Management in the Hospital Setting Alexandra Phan, PharmD PGY-1 Pharmacy Practice Resident Medical Center Hospital Odessa, TX 2 What is Pain? An unpleasant sensory and emotional experience associated
More informationPain Management Management in Hepatic Hepatic and and Renal Dysfunction
Pain Management in Hepatic and Renal Dysfunction Review the pharmacologic basis for medications used in pain management Identify pain medications which hshould ldbe avoided in patients with hepatic dysfunction
More informationOAT Transitions - focus on microdosing. Mark McLean MD MSc FRCPC CISAM DABAM
OAT Transitions - focus on microdosing Mark McLean MD MSc FRCPC CISAM DABAM Disclosures No pharmaceutical industry or other financial conflicts of interest Study Physician for research funded by Canadian
More information1
Disclosures I do not have a vested interest in or affiliation with any corporate organization offering financial support or grant monies for this continuing education activity, or any affiliation with
More informationCoversheet for Network Site Specific Group Agreed Documentation
Coversheet for Network Site Specific Group Agreed Documentation This sheet is to accompany all documentation agreed by Pan Birmingham Cancer Network Site Specific Groups. This will assist the Network Governance
More informationLearning Objectives. Case Example. From Coke to Pepsi or a cocktail? Rotating and adding opioids in advanced pediatric pain medicine
From Coke to Pepsi or a cocktail? Rotating and adding opioids in advanced pediatric pain medicine Stefan J. Friedrichsdorf, MD, FAAP Associate Professor of Pediatrics, University of Minnesota Medical School
More informationPractical Tools to Successfully Taper Prescription Opioids. Melissa Weimer, DO, MCR
Practical Tools to Successfully Taper Prescription Opioids Melissa Weimer, DO, MCR Objectives Understand how to calculate morphine equivalents per day Understand the steps necessary to plan a successful
More informationRegional Renal Training
Regional Renal Training Palliative and End of Life Care Dr Clare Kendall North Bristol NHS Trust Advanced Kidney Disease Dialysis/Transplant Conservative Management Deteriorating despite dialysis/failing
More informationOpioid rotation or switching may be considered if a patient obtains pain relief with one opioid and is suffering severe adverse effects.
Dose equivalence and switching between opioids Key Messages Switching from one opioid to another should only be recommended or supervised by a healthcare practitioner with adequate competence and sufficient
More informationOpioid Conversion Ratios - Guide to Practice 2010
Opioid Conversion Ratios - Guide to Practice 2010 Released December 2010. 2010. The EMR PCC grants permission to reproduce parts of this publication for clinical and educational use only, provided that
More informationGUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT (estimated glomerular filtration rate<30)
GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT These guidelines have been produced in collaboration with Dr Lucy Smyth, Consultant in Renal Medicine, Royal Devon and Exeter
More informationClinical Guideline. Guidelines for the use of opioid analgesics in the management of acute pain in adults
Clinical Guideline Guidelines for the use of opioid analgesics in the management of acute pain in adults Document detail Document location West Kent and MTW Formulary Version 1.0 Effective from July 2017
More informationPain. November 1, 2006 Dr. Jana Pilkey MD, FRCP(C) Internal Medicine, Palliative Medicine
Pain November 1, 2006 Dr. Jana Pilkey MD, FRCP(C) Internal Medicine, Palliative Medicine Objectives To be able to define pain To be able to evaluate pain To be able to classify types of pain To learn appropriate
More informationPain and the MGH Promise
Pain is an unpleasant sensory & emotional experience associated with actual or potential tissue damage or described in terms of such damage Our promise to patients we will always: Work as a team to evaluate,
More informationDrug Information Common to the Class of Extended-Release and Long-Acting Opioid Analgesics (ER/LA opioid analgesics) Avinza Butrans
FDA Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioid Analgesics 7/9/2012 Drug Information Common to the Class of Extended-Release and Long-Acting Opioid Analgesics (ER/LA
More informationMorphine er to oxycontin conversion
Morphine er to oxycontin conversion The Borg System is 100 % Morphine er to oxycontin conversion 17-4-2011 Conversion dose from Oxycontin 40mg 3x a day to morphine sulfate 15 mg?. Oxycontin vs morphine
More informationPain: What You Need to Know to Advocate
Pain: What You Need to Know to Advocate Amy M. Corcoran, MD Assistant Professor of Clinical Medicine Department of Medicine, Division of Geriatrics University of Pennsylvania Associate Medical Director
More informationPAIN MANAGEMENT Patient established on oral morphine or opioid naive.
PAIN MANAGEMENT Patient established on oral morphine or opioid naive. Important; It is the responsibility of the prescriber to ensure that guidelines are followed when prescribing opioids. Every member
More informationEnd-of-Life Pain Management: How to do it right Wayne Kohan MD Medical Director Chaplaincy Hospice Care
End-of-Life Pain Management: How to do it right Wayne Kohan MD Medical Director Chaplaincy Hospice Care Objectives Discuss the rational use of opioid medications, including dosing and dose titration, routes
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Reference Number: CP.CPA.259 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Commercial Revision Log See Important Reminder at the end of this policy for important regulatory
More informationSYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL
SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL If a patient is believed to be approaching the end of their life, medication should be prescribed in anticipation
More informationDoncaster & Bassetlaw Cancer Locality. Palliative Care Core Formulary
Doncaster & Bassetlaw Cancer Locality Palliative Core Formulary Approved by Doncaster & Bassetlaw Hospitals NHS Foundation Trust Drugs and Therapeutics Committee. DJ14/2155 Oct 2014 Review date: Oct 2017
More informationPalliative Emergencies. Ken Stakiw
Palliative Emergencies Ken Stakiw Disclosure None to disclose for this lecture Have received honoraria from a number of agencies and companies previously Intend to discuss some off label use of medications
More informationAnalgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti-
Page 1 of 8 Analgesia The World Health Organisation (WHO, 1990) has devised a model to assist health care professionals in the management of cancer pain. The recommendations include managing pain, by the
More informationMMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life
MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life The following pages are guidelines for the management of common symptoms for a person thought to be
More information2-ethylidene-1,5-dimethyl-3,3diphenylpyrrolidene (EDDP) Safe in stable liver disease Long acting
2012 AAHPM & HPNA Annual Assembly March 7-10, 2012 Denver, CO Methadone the Taming of the Shrew Stefan J. Friedrichsdorf, M.D. Medical Director Department of Pain Medicine, Palliative Care & Integrative
More informationPAIN MANAGEMENT IN PATIENTS WITH CANCER, PART II
Learning Objectives PAIN MANAGEMENT IN PATIENTS WITH CANCER, PART II MINA LEE UNIVERSITY OF WASHINGTON MEDICAL CENTER/ SEATTLE CANCER CARE ALLIANCE CLINICAL PHARMACIST, GENERAL ONCOLOGY Understand the
More informationSTARSHIP WITHDRAWAL OF ANALGESIA AND SEDATION
STARSHIP WITHDRAWAL OF ANALGESIA AND SEDATION Patients receiving analgesia and/or sedation for longer than 5-7 days may suffer withdrawal if these drugs are suddenly stopped. To prevent this happening
More informationPain Management in the Hospital
E P E C O Pain Management in the Hospital Denise Waugh, MD FACEP FAAHPM Medical Director of Palliative Care Services Scott and White Healthcare 724-6859 Pain is a more terrible lord of mankind than even
More information